NASDAQ (usa) | 6715.56 | -12.11 | -0.18% | |
FTSE 100 (london) | 7487.96 | -5.12 | -0.07% | |
DAX (german) | 13465.51 | 235.94 | 1.78% | |
NIKKEI 225 (japan) | 22420.08 | 408.47 | 1.86% | |
Hang - Seng (hong kong) | 28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) | 3391.61 | 17.53 | 0.52% | |
KOSPI (korea) | 2556.47 | 33.04 | 1.31% | |
All Ordinaries (australia) | 6005.30 | 28.90 | 0.48% | |
BOVESPA (brazil) | 74092.76 | -215.73 | -0.29% |
Quantum Genomics Société Anonyme (PA: ALQGC)
ALQGC Technical Analysis
5
As on 20th Dec 2024 ALQGC STOCK Price closed @ 0.07 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.12 & Strong Sell for SHORT-TERM with Stoploss of 0.15 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ALQGCSTOCK Price
Open | 0.07 | Change | Price | % |
High | 0.07 | 1 Day | 0.00 | 0.00 |
Low | 0.07 | 1 Week | 0.00 | 0.00 |
Close | 0.07 | 1 Month | 0.00 | 0.00 |
Volume | N/A | 1 Year | -0.08 | -53.33 |
52 Week High 0.17 | 52 Week Low 0.01 |
PA France Most Active Stocks
ATO | 0.00 | % |
FTI | 5.91 | -1.66% |
VIV | 2.51 | 2.45% |
VIEDS | 0.72 | 4.35% |
ORA | 9.44 | -0.32% |
ACA | 13.01 | -0.46% |
TTE | 51.89 | -0.08% |
CS | 33.51 | -0.80% |
ENGI | 14.91 | 0.61% |
ALVER | 0.00 | % |
PA France Top Gainers Stocks
PA France Top Losers Stocks
ALQGC Daily Charts |
ALQGC Intraday Charts |
Whats New @ Bazaartrend |
ALQGC Free Analysis |
|
ALQGC Important Levels Intraday
RESISTANCE | 0.07 |
RESISTANCE | 0.07 |
RESISTANCE | 0.07 |
RESISTANCE | 0.07 |
RESISTANCE | 0.07 |
RESISTANCE | 0.07 |
RESISTANCE | 0.07 |
RESISTANCE | 0.07 |
ALQGC Forecast December 2024
4th UP Forecast | 0.15 |
3rd UP Forecast | 0.12 |
2nd UP Forecast | 0.11 |
1st UP Forecast | 0.09 |
1st DOWN Forecast | 0.05 |
2nd DOWN Forecast | 0.03 |
3rd DOWN Forecast | 0.02 |
4th DOWN Forecast | -0.01 |
ALQGC Weekly Forecast
4th UP Forecast | 0.09 |
3rd UP Forecast | 0.08 |
2nd UP Forecast | 0.08 |
1st UP Forecast | 0.08 |
1st DOWN Forecast | 0.06 |
2nd DOWN Forecast | 0.06 |
3rd DOWN Forecast | 0.06 |
4th DOWN Forecast | 0.05 |
ALQGC Forecast2024
4th UP Forecast | 0.46 |
3rd UP Forecast | 0.33 |
2nd UP Forecast | 0.26 |
1st UP Forecast | 0.18 |
1st DOWN Forecast | -0.04 |
2nd DOWN Forecast | -0.12 |
3rd DOWN Forecast | -0.19 |
4th DOWN Forecast | -0.32 |
Quantum Genomics Société Anonyme ( PA France Symbol : ALQGC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
ALQGC Other Details
Segment | EQ | |
Market Capital | 112396752.00 | |
Sector | Healthcare | |
Industry | Biotechnology | |
Offical website | > echo $website ; ?> |
ALQGC Address
ALQGC Latest News
ALQGC Business Profile
Quantum Genomics Société Anonyme, a biopharmaceutical company, develops drugs to treat cardiovascular diseases. It develops drugs based on brain aminopeptidase A inhibition (BAPAI) platform primarily to treat high blood pressure and heart failure. The company develops firibastat, a monotherapy drug that is in pivotal Phase III study for the treatment of hypertension; and in Phase IIb clinical trial for heart failure. It is also developing QGC011 that is in pre-clinical phase to treat hypertension with combination therapy; and QGC006 to optimize the treatment of hypertension with a monotherapy drug. The company was founded in 2005 and is based in Paris, France. Address: 33, rue Marbeuf, Paris, France, 75008
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service